Torrent Pharmaceuticals Limited

NSE:TORNTPHARM.NS

Location

Market Cap

USD 13.20 B

Share Price

USD 38.57

Avg Daily Volume

411,987

Change (1 day)

-0.96%

Change (1 year)

8.96%

Change (YTD)

-1.74%

Torrent Pharmaceuticals Limited EBITDA Margin for the year ending March 31, 2025: 32.31%

Torrent Pharmaceuticals Limited EBITDA Margin is 32.31% for the year ending March 31, 2025, a -2.12% change year over year. EBITDA Ratio is the proportion of Earnings Before Interest, Taxes, Depreciation, and Amortization to total revenue, assessing a company's operational profitability before non-operating expenses and non-cash charges.
  • Torrent Pharmaceuticals Limited EBITDA Margin for the year ending March 31, 2024 was 33.01%, a 8.38% change year over year.
  • Torrent Pharmaceuticals Limited EBITDA Margin for the year ending March 31, 2023 was 30.46%, a 19.66% change year over year.
  • Torrent Pharmaceuticals Limited EBITDA Margin for the year ending March 31, 2022 was 25.45%, a -20.86% change year over year.
  • Torrent Pharmaceuticals Limited EBITDA Margin for the year ending March 31, 2021 was 32.16%, a 9.33% change year over year.
Key Data
Date EBITDA Margin Net Income Margin EBT Margin Operating Income Margin